Latest News About Lyme Disease

Here are the latest notable updates on Lyme disease from reputable sources:

• Johns Hopkins Lyme Disease Research Center highlights ongoing findings and recent headlines, including a notable 2025 report reinforcing that Lyme disease is not psychosomatic and celebrating the center’s 10th anniversary. This points to continued emphasis on recognition, diagnosis, and research progress in Lyme care.[1]

• Scientific Daily reports a 2025 breakthrough identifying an enzyme in the Lyme disease pathogen as a promising target for new therapies, suggesting potential future treatments that could improve outcomes for patients with tick-borne diseases. This reflects active therapeutic development in the field.[4]

• CBS-affiliated outlets in 2025-2023 covered vaccine development efforts, including Pfizer’s work on a potential Lyme vaccine and related discussions about vaccines from Moderna and Pfizer, indicating ongoing pursuit of preventive options amid rising tick exposure in some regions.[3]

• Regional outlets have tracked policy and public health responses to Lyme disease, including tracking hotspots and legislation aimed at monitoring and mitigating exposure risks, illustrating the public health community’s focus on prevention and surveillance.[2]

• LymeDisease.org and other patient-focused outlets continue to report on epidemiology, testing advances, and patient advocacy efforts, underscoring ongoing debates about diagnosis, access to care, and equitable treatment.[6]

If you’d like, I can pull the most recent articles from these sources and summarize key findings in a brief, date-stamped digest or assemble a chart of recent developments (e.g., major studies, vaccine updates, and policy actions) with links. Would you prefer a quick bulleted digest or a summarized chart? I can also tailor to your location in Los Angeles or focus on travel, outdoor activities, or clinical care updates. Citation note: I’ve drawn from Johns Hopkins Lyme News, Science Daily, CBS/ABC news aggregations, and Lyme-focused outlets to reflect the latest publicly reported items.